Best Practice & Research Clinical Haematology
Volume 19, Issue 3 , Pages 519-533, September 2006

Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders

  • Bart Scott (Member, Fred Hutchinson Cancer Research CenterProfessor of Medicine, University of Washington, Seattle, WA)
    • ,
  • H. Joachim Deeg (Research Associate, Fred Hutchinson Cancer Research CenterActing Instructor, University of Washington, Seattle, WA)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 206 288 1024; Fax: +1 206 667 6124.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1024, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(05)00096-4

doi:10.1016/j.beha.2005.07.009

Best Practice & Research Clinical Haematology
Volume 19, Issue 3 , Pages 519-533, September 2006

Article Tools

* Image Usage & Resolution